1-7 of 7
Yizhen Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Features, Management and Prognostic Factors of Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Yizhen Liu, Lingyu Liu, Chuanxu Liu, Wenhao Zhang, Shiyu Jiang, Qunling Zhang, Fangfang Lyu, Xiaojian Liu, Junning Cao, Xuejun Ma, Rong Tao
Journal: Blood
Blood (2024) 144 (Supplement 1): 1653.
https://doi.org/10.1182/blood-2024-202237
Published: 2024
Journal Articles

Phase II Clinical Trial on Chidamide, Rituximab and High-Dose Methotrexate (C-R-HDMTX) in Newly Diagnosed Primary CNS Lymphoma

Guang-Liang Chen, Jia Jin, Hui Sun, Yizhen Liu, Qunling Zhang, Zuguang Xia, Junning Cao, Xiaonan Hong, Fangfang Lv
Journal: Blood
Blood (2024) 144 (Supplement 1): 6526.
https://doi.org/10.1182/blood-2024-194111
Published: 2024
Journal Articles

A Phase II Study of Chidamide Plus R-GDP Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Transplantation: Efficacy and Safety Analysis

Guangliang Chen, Kai Xue, Qunling Zhang, Jia Jin, Yizhen Liu, Zuguang Xia, Fangfang Lyu, Xiaonan Hong, Xiaoqiu LI, Junning Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 5805.
https://doi.org/10.1182/blood-2023-174307
Published: 2023
Journal Articles

Clinical Predictors of Central Nervous System Relapse in Primary Breast Diffuse Large B-Cell Lymphoma

Guang-Liang Chen, Pin Guo, Shiyu Jiang, Juan J. Gu, Qunling Zhang, Yizhen Liu, Junning Cao, Xiaonan Hong, Rong TAO, Fangfang Lv
Journal: Blood
Blood (2022) 140 (Supplement 1): 3790–3791.
https://doi.org/10.1182/blood-2022-156877
Published: 2022
Journal Articles

Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial

Yizhen Liu, Qunling Zhang, Fangfang Lv, Xiaojian Liu, Dongmei Ji, Zuguang Xia, Jia Jin, Rong TAO, Wenhao Zhang, Xiaoqiu Li, Shengjian Zhang, Jiachen Wang, Xiaonan Hong, Junning Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6627–6628.
https://doi.org/10.1182/blood-2022-158657
Published: 2022
Journal Articles

Inhibitor of DNA Binding 3 Is a Potential Prognostic Biomarker in Non-GCB Diffuse Large B-Cell Lymphoma

Qunling Zhang, Jichuan Wu, Juan J. Gu, Yizhen Liu, Zuguang Xia, Lan Wang, Xiaonan Hong, Junning Cao
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-141887
Published: 2020
Journal Articles

Hexokinase II Expression As a Prognosis Marker in Diffuse Large B-Cell Lymphoma (DLBCL) Pre- and Post- the Incorporation of Rituximab to Standard CHOP Chemotherapy

Juan J. Gu, MD PhD, Yizhen Liu, MD PhD, Jia Jin, Ling Yang, Zuguang Xia, Xiaojian Liu, Fangfang Lv, MD, Francisco J. Hernandez-Ilizaliturri, MD, Xiaonan Hong, Junning Cao, MD, Qunling Zhang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5233.
https://doi.org/10.1182/blood-2019-128878
Published: 2019